Healthy people test new drug MF-300 for safety
NCT ID NCT07613684
First seen Jun 09, 2026 · Last updated Jun 15, 2026 · Updated 3 times
Summary
This early-stage study tested the safety of a new drug called MF-300 in 100 healthy adults. Participants received either a single dose or multiple doses to see how the drug moves through the body and what side effects occur. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 101
Austin, Texas, 78744, United States
-
Site 102
Marlton, New Jersey, 08053, United States
Conditions
Explore the condition pages connected to this study.